Civica Pairs With Fresenius Kabi To Supply Stelara Biosimilar

Unbranded Ustekinumab-aauz Version Is Set To Launch From January 2026

 
• By Dave Wallace
  
Civica is partnering with Fresenius Kabi (Shutterstock)

More from Deals

More from Business